Pricing

Centessa Pharmaceuticals PLC (CNTA)

followers ·
Sector: HEALTH CARE
Industry: BIOTECHNOLOGY & LIFE SCIENCES
CEO: Saurabh Saha
Employees: 200
Web site: centessa.com
3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE, X0, WA14 2DT
44 7391 789784
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Centessa Pharmaceuticals plc discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor. SerpinPC, an activated protein C inhibitor, is in Phase IIa clinical development for the treatment of hemophilia A and B. The company also has emerging pipeline products under clinical proof of concept stage.
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available